
Sign up to save your podcasts
Or


In this episode, we speak with Associate Professor Leszek Lisowski, Head of the Translational Vectorology Unit at the Children's Medical Research Institute (CMRI), about the cutting-edge world of gene therapy. He explains how viral vectors are engineered to deliver life-saving treatments for rare genetic diseases - many of which are so uncommon, they're only known by the name of the affected gene. Despite being often overlooked, genetic diseases impact 10% of adults and 30% of children in hospitals. Leszek sheds light on the challenges of diagnosis, the promise of emerging genetic testing, and how his work is paving the way for more accurate, effective therapies.
Linkedin: Children's Medical Research Institute, Leszek Lisowski
Facebook: @jeansforgenes
Instagram: @jeansforgenesau
By Dr Karl Kruszelnicki4.2
3636 ratings
In this episode, we speak with Associate Professor Leszek Lisowski, Head of the Translational Vectorology Unit at the Children's Medical Research Institute (CMRI), about the cutting-edge world of gene therapy. He explains how viral vectors are engineered to deliver life-saving treatments for rare genetic diseases - many of which are so uncommon, they're only known by the name of the affected gene. Despite being often overlooked, genetic diseases impact 10% of adults and 30% of children in hospitals. Leszek sheds light on the challenges of diagnosis, the promise of emerging genetic testing, and how his work is paving the way for more accurate, effective therapies.
Linkedin: Children's Medical Research Institute, Leszek Lisowski
Facebook: @jeansforgenes
Instagram: @jeansforgenesau

97 Listeners

600 Listeners

123 Listeners

56 Listeners

882 Listeners

201 Listeners

760 Listeners

131 Listeners

69 Listeners

68 Listeners

352 Listeners

40 Listeners

234 Listeners

46 Listeners

108 Listeners